glp 1 for type 2 diabetes Glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide analogues in adults with mellitus glycaemic control GLP-1 Receptor Agonist Shortage: Challenges
Description
Common adverse effects are gastrointestinal and usually dose-related
Obesity also increases the risk of cardiovascular disease, where 5 kg increases in weight in adults is associated with an 11% higher risk of death from cardiovascular disease (strokes, coronary heart disease, myocardial infarction etc)
Ensuring adequate protein intake significantly reduces this side effect, which connects to our nutrition section below
Set Points approach includes combining medication with personalized lifestyle changes such as nutrition and exercise plans to optimize results
This screening is a fundamental safety measure and should be documented in the patient's medical records
A decrease in their level directly affects protein synthesis, which leads to a decrease in muscle mass [169]
